510(k) · Cleared
ClearedALP VasQcare Take Home System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Currie Medical Specialties, Inc. · JOW Sleeve, Limb, Compressible
Cleared on Dec 10, 2015 as substantially equivalent to K112311 (Currie Medical Specialties, Inc., 2011) and 2 other predicates after a 223-day review. Its family tree reaches back 5 generations to 1992.
- Decided
- Dec 10, 2015
- Review
- 223 days
- Class
- Class II
- Product code
- JOW
- Recalls
- None
- Predicates
- 3
Its longest line of descent runs back 5 generations to K915638 (1992). 17 ancestors in all. No later device cites it as a predicate yet.
- Root · 5 generations backK915638 Talley TM200 Intermttent Compression UnitProgressive Medical Technology, Inc. · 1992
- 4 generations backK022340 Travelair Portable Compression SystemDynamic Air, Inc. · 2003
- 3 generations backK061125 Dvtcare CA5Doctors Orders · 2006
- 2 generations backK103187 Tripleplay-VT Vascular Therapy SystemWildcat Medical, Inc. · 2011
- 1 generation backK133274 Vena ProInnovamed Health, LLC · 2014
- This deviceK151158 ALP VasQcare Take Home SystemCurrie Medical Specialties, Inc. · 2015
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −5 | K915638 | Talley TM200 Intermttent Compression Unit | Progressive Medical Technology, Inc. | 1992 | — |
| −4 | K022340 | Travelair Portable Compression System | Dynamic Air, Inc. | 2003 | — |
| −3 | K061125 | Dvtcare CA5 | Doctors Orders | 2006 | — |
| −2 | K103187 | Tripleplay-VT Vascular Therapy System | Wildcat Medical, Inc. | 2011 | — |
| −1 | K133274 | Vena Pro | Innovamed Health, LLC | 2014 | — |
| 0 (this device) | K151158 | ALP VasQcare Take Home System | Currie Medical Specialties, Inc. | 2015 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 1 | 0 |
| 2005 | 1 | 0 |
| 2006 | 1 | 0 |
| 2011 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in JOW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new JOW device
- #1 K253555 Flexitouch® Plus Advanced Pneumatic…score 14.8 · 11 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K112311 | Alp 501 RB Pump SystemSummary page 4…Cardiovascular Regulation Number: 870.5800 Classification: Class II Predicate Device(s): K112311 – Currie Medical Specialties, ALP 501RB System K133274 – Innovamed Health LLC, Vena Pro… | 2011 |
| * | K133274 | Vena ProSummary page 4…Class II Predicate Device(s): K112311 – Currie Medical Specialties, ALP 501RB System K133274 – Innovamed Health LLC, Vena Pro K061125 – Doctors Order, DVTcare CA5 Device Description… | 2014 |
| * | K061125 | Dvtcare CA5Summary page 4…1 – Currie Medical Specialties, ALP 501RB System K133274 – Innovamed Health LLC, Vena Pro K061125 – Doctors Order, DVTcare CA5 Device Description: Currie Medical Specialties (CMS) ALP® VasQcare™ System provides intermittent p… | 2006 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 23 years and passes through 6 companies; a new generation was cleared every 3.3 years on median.
- 2 of the 17 ancestors have a recall of any class.
How does its category compare?
All JOW devicesJOW Sleeve, Limb, Compressible: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.
FDA decisions per year · JOW
7in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · JOW
168in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · JOW
1in 2019
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · JOW
24in 2025
MAUDE reports naming product code JOW, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 6 | 66 | 0 | 12 |
| 2008 | 4 | 112 | 7 | 36 |
| 2009 | 3 | 84 | 0 | 45 |
| 2010 | 18 | 71 | 2 | 66 |
| 2011 | 11 | 104 | 3 | 50 |
| 2012 | 13 | 63 | 2 | 100 |
| 2013 | 17 | 94 | 0 | 169 |
| 2014 | 16 | 91 | 0 | 93 |
| 2015 | 10 | 160 | 0 | 137 |
| 2016 | 9 | 121 | 0 | 150 |
| 2017 | 9 | 116 | 1 | 149 |
| 2018 | 11 | 136 | 0 | 114 |
| 2019 | 11 | 88 | 1 | 102 |
| 2020 | 14 | 158 | 0 | 50 |
| 2021 | 16 | 132 | 0 | 34 |
| 2022 | 7 | 80 | 0 | 27 |
| 2023 | 6 | 160 | 0 | 57 |
| 2024 | 8 | 197 | 0 | 30 |
| 2025 | 7 | 168 | 0 | 24 |
| 2026 | 6 | 252 | 0 | — |
What is it indicated for?
The Alternating Leg Pressure® (ALP®) VasQcare™ System is a non-invasive system for reducing the incidence of deep vein thrombosis. The application of external intermittent pneumatic compression has six effects: 1. Increases blood flow velocity 2. Reduces the risk of deep vein thrombosis 3. Enhances blood circulation 4. Reduces pain and swelling 5. Reduces wound healing time 6. Aids in the treatment and healing of stasis dermatitis, venous stasis…
Read the full statement (203 words)
The Alternating Leg Pressure® (ALP®) VasQcare™ System is a non-invasive system for reducing the incidence of deep vein thrombosis. The application of external intermittent pneumatic compression has six effects:
1. Increases blood flow velocity
2. Reduces the risk of deep vein thrombosis
3. Enhances blood circulation
4. Reduces pain and swelling
5. Reduces wound healing time
6. Aids in the treatment and healing of stasis dermatitis, venous stasis, arterial and diabetic leg ulcers, chronic vein insufficiency and reduction of edema in the lower limbs
The ALP® VasQcare™ System consists of a pump and a pair of single use calf sleeves. The pump provides intermittent cycles of compressed air, which alternately inflate the calf sleeves. The compression, when applied properly to the patient, increases blood velocity back to the heart and helps to prevent deep vein thrombosis.
The pump operates on timed cycles consisting of approximately 12 seconds of inflation where the calf sleeve compresses the limb followed by approximately 48 seconds of deflation where there is no pressure applied to the limb. Each limb compresses once per minute.
The ALP® VasQcare™ System may be used on patients at risk for developing deep vein thrombosis and in conjunction with medical therapy for high-risk patients.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K151158 · printed Nov 6, 2026
Cite this page
510(k) Report. “K151158: ALP VasQcare Take Home System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K151158
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026